![]()
|
|
||||||||
(Received for publication, April 30, 1996, and in revised form, July 5, 1996)
From the Department of Psychiatry and Behavioral Science, State
University of New York at Stony Brook, Stony Brook, New York 11794-8101 and the § McArdle Laboratory for Cancer Research, University
of Wisconsin Medical School, Madison, Wisconsin 53706-1599
The TATA-less human amyloid
Volume 271, Number 36,
Issue of September 6, 1996
pp. 22231-22239
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
-Protein Precursor Promoter
-protein precursor
promoter contains an initiator element with the sequence
CGTCA+1GTT. Primary transcriptional start sites were
identified at positions +1 and
4. Deletion of the upstream activator
elements APB
and APB
did not affect the selection of
transcriptional start sites, although total transcriptional activity
was reduced both in vitro and in vivo.
Mutations within the initiator element shifted the transcriptional
start sites and reduced transcriptional activity. Mutations between
positions
6 and
35 changed the relative utilization of start sites
+1 and
4 without affecting the total level of transcriptional
activity. A 10-base pair deletion between position
40 and
31
increased in vitro transcriptional activity with a
preeminent utilization of the start site at position
4. In contrast,
a 20-base pair deletion between position
40 and
21 resulted in a
reduction in transcriptional activity and in the primary utilization of
the start site at position +1. Furthermore, transactivation by APB
and APB
was eliminated. DNase I footprinting provided evidence for
the existence of two binding domains designated UE (position
12 to
30) and Inr (position +7 to
7). The positions of these binding
domains are altered in mutations and deletions that affect
transcriptional activity.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. S. Athan, J. H. Lee, A. Arriaga, R. P. Mayeux, and B. Tycko Polymorphisms in the Promoter of the Human APP Gene: Functional Evaluation and Allele Frequencies in Alzheimer Disease Arch Neurol, November 1, 2002; 59(11): 1793 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Theuns and C. Van Broeckhoven Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility Hum. Mol. Genet., October 1, 2000; 9(16): 2383 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Quitschke, M. J. Taheny, L. J. Fochtmann, and A. A. Vostrov Differential effect of zinc finger deletions on the binding of CTCF to the promoter of the amyloid precursor protein gene Nucleic Acids Res., September 1, 2000; 28(17): 3370 - 3378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Vostrov and W. W. Quitschke The Zinc Finger Protein CTCF Binds to the APBbeta Domain of the Amyloid beta -Protein Precursor Promoter. EVIDENCE FOR A ROLE IN TRANSCRIPTIONAL ACTIVATION J. Biol. Chem., December 26, 1997; 272(52): 33353 - 33359. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Vostrov, M. J. Taheny, and W. W. Quitschke A Region to the N-terminal Side of the CTCF Zinc Finger Domain Is Essential for Activating Transcription from the Amyloid Precursor Protein Promoter J. Biol. Chem., January 4, 2002; 277(2): 1619 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Vostrov and W. W. Quitschke Plasma Hyaluronan-binding Protein Is a Serine Protease J. Biol. Chem., July 21, 2000; 275(30): 22978 - 22985. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |